Fasted C-Peptide Distribution and Associated Clinical Factors in Adults With Longstanding Type 1 Diabetes: Analysis of the Canadian Study of Longevity in Type 1 Diabetes
Sebastien O. Lanctôt(Mount Sinai Hospital), Bruce A. Perkins(Sinai Health System), Michael H. Brent(University of Toronto), Michelle Morris, Abdulmohsen Bakhsh(Alfaisal University), David Z.I. Cherney(University Health Network), Leif E. Lovblom(University of Toronto), Nancy Cardinez(Mount Sinai Hospital), Yuliya Lytvyn(University Health Network), Vera Bril(University Health Network), Julie A. Lovshin(Sunnybrook Health Science Centre), Evan J.H. Lewis(Mount Sinai Hospital), Geneviève Boulet(University of Toronto), Alexandra Bussières(Université de Sherbrooke), Mohammad I. Abuabat, Narinder Paul, Daniel Scarr(Mount Sinai Hospital)
Cited by 1
Related Papers
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
|The Lancet|2022|1k
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
|Circulation|2017|470
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
|The Lancet|2023|343
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer
|Journal of Clinical Oncology|2023|332
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial
|Nephrology Dialysis Transplantation|2019|216